{
    "clinical_study": {
        "@rank": "112603", 
        "arm_group": [
            {
                "arm_group_label": "Hypofractionated Arm (1)", 
                "arm_group_type": "Active Comparator", 
                "description": "A total dose of 39 Gy in daily fractions of 3 Gy, 5 Fractions per week , by conformal radiotherapy sparing of the supratentorial brain. The planning target volume included the tumor as defined by the T2-weighted MRI images with a margin of 1.5-2.0 cm. Margins were adjusted for bony structures and tentorium. With exception of steroids, no neoadjuvant, concomitant, or adjuvant systemic treatment was allowed"
            }, 
            {
                "arm_group_label": "Hypofractionated Arm (2)", 
                "arm_group_type": "Active Comparator", 
                "description": "The same planning and treatment procedures will be performed. The total dose will be 4500 cGy in 15 fractions in 3 weeks; giving 300 cGy per fraction."
            }, 
            {
                "arm_group_label": "Conventional Arm (3)", 
                "arm_group_type": "Other", 
                "description": "The same planning and treatment procedures will be performed with 54.0 Gy in 30 fractions giving 1.8 Gy per fraction."
            }
        ], 
        "brief_summary": {
            "textblock": "This Trial offers a reduction in patient burden, which is especially preferable in children\n      with a poor compliance and poor performance status. This prospective randomized trial was\n      extension to the previous controlled prospective study performed in Children's Cancer\n      Hospital, Egypt and registered at clinicaltrials.com (NCT01635140). The ultimate aim of this\n      work is to demonstrate noninferiority of the hypofractionated regimens relative to the\n      conventional regimen in a controlled randomized clinical study."
        }, 
        "brief_title": "Prospective Trial of Two Hypofractionated Radiotherapy Regimens Versus Conventional Radiotherapy in Diffuse Brainstem Glioma in Children", 
        "completion_date": {
            "#text": "December 2013", 
            "@type": "Anticipated"
        }, 
        "condition": "Pediatric Brain Stem Glioma", 
        "condition_browse": {
            "mesh_term": "Glioma"
        }, 
        "detailed_description": {
            "textblock": "In this study will add a third arm in which we will increase in the total dose to 4500 cGy\n      in 15 fractions in 3 weeks may lead to improvement in Over-all survival or Progression-Free\n      Survival."
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          1. Newly diagnosed patients with a diffuse intrinsic brainstem glioma\n\n          2. Aged  2-18years,\n\n          3. Have symptoms for less than 3 months and at least two findings of the    neurologic\n             triad: cranial nerve deficits, ataxia, or long tract signs.\n\n          4. No performance criteria were required for entry onto the study.\n\n        Exclusion Criteria:\n\n          -  Children were not eligible if they had received any prior therapy other than steroids\n             Treatment"
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "18 Years", 
            "minimum_age": "2 Years"
        }, 
        "enrollment": {
            "#text": "119", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "June 9, 2013", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT01878266", 
            "org_study_id": "CCHE-BT002"
        }, 
        "intervention": [
            {
                "arm_group_label": "Hypofractionated Arm (1)", 
                "description": "A total dose of 39 Gy in daily fractions of 3 Gy, 5 Fractions per week", 
                "intervention_name": "Hypofractionated Arm (1)", 
                "intervention_type": "Radiation"
            }, 
            {
                "arm_group_label": "Hypofractionated Arm (2)", 
                "description": "The total dose to 4500 cGy in 15 fractions in 3 weeks", 
                "intervention_name": "Hypofractionated Arm (2)", 
                "intervention_type": "Radiation"
            }, 
            {
                "arm_group_label": "Conventional Arm (3)", 
                "description": "A total dose of 54 Gy in 30 fractions giving 1.8 Gy per fraction.Conventional arm", 
                "intervention_name": "Conventional Arm (3)", 
                "intervention_type": "Radiation"
            }
        ], 
        "is_fda_regulated": "No", 
        "keyword": [
            "Diffuse Intrinsic Pontine Glioma (DIPG)", 
            "Hypofractionated Radiotherapy", 
            "Radiotherapy", 
            "Median survival"
        ], 
        "lastchanged_date": "June 12, 2013", 
        "location": {
            "contact": {
                "email": "mszagh@yahoo.com", 
                "last_name": "Mohamed S zaghloul, MD", 
                "phone": "202-25351500", 
                "phone_ext": "1192"
            }, 
            "facility": {
                "address": {
                    "city": "Cairo", 
                    "country": "Egypt", 
                    "zip": "11441"
                }, 
                "name": "Children's Cancer Hospital Egypt 57357"
            }, 
            "investigator": {
                "last_name": "Mohamed S Zaghloul, MD", 
                "role": "Principal Investigator"
            }, 
            "status": "Recruiting"
        }, 
        "location_countries": {
            "country": "Egypt"
        }, 
        "number_of_arms": "3", 
        "official_title": "Prospective Randomized Trial of Two Hypofractionated Radiotherapy Regimens Versus Conventional Radiotherapy in Pediatric Diffuse Brainstem Glioma", 
        "overall_contact": {
            "email": "mszagh@yahoo.com", 
            "last_name": "Mohamed S Zaghloul, MD", 
            "phone": "(202)25351500", 
            "phone_ext": "1192"
        }, 
        "overall_contact_backup": {
            "email": "waffa.rashed@57357.com", 
            "last_name": "Wafaa M Rashed, Pharm b", 
            "phone": "202-25351500", 
            "phone_ext": "7209"
        }, 
        "overall_status": "Recruiting", 
        "oversight_info": {
            "authority": "Egypt: Institutional Review Board", 
            "has_dmc": "Yes"
        }, 
        "phase": "Phase 3", 
        "primary_completion_date": {
            "#text": "August 2013", 
            "@type": "Anticipated"
        }, 
        "primary_outcome": {
            "measure": "Median overall-free survival", 
            "safety_issue": "Yes", 
            "time_frame": "3 years"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT01878266"
        }, 
        "responsible_party": {
            "responsible_party_type": "Sponsor"
        }, 
        "secondary_outcome": {
            "measure": "Progression-free survival", 
            "safety_issue": "Yes", 
            "time_frame": "3 years"
        }, 
        "source": "Children's Cancer Hospital Egypt 57357", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "Children's Cancer Hospital Egypt 57357", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "February 2013", 
        "study_design": "Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Treatment", 
        "study_type": "Interventional", 
        "verification_date": "June 2013"
    }
}